Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae

Published:2018-03-28 Issue:4 Volume:38 Page:444-461
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Jorgensen Sarah Christina Jane¹,Rybak Michael Joseph¹²³^ORCID

Affiliation:

1. Anti-infective Research Laboratory; Eugene Applebaum College of Pharmacy and Health Sciences; Wayne State University; Detroit Michigan

2. Division of Infectious Diseases; Department of Medicine; School of Medicine; Wayne State University; Detroit Michigan

3. Department of Pharmacy Services; Detroit Medical Center; Detroit Michigan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference80 articles.

1. Gram-Negative bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group;Doi;Clin Infect Dis,2017

2. Carbapenemases: the versatile beta-lactamases;Queenan;Clin Microbiol Rev,2007

3. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection;Hirsch;J Antimicrob Chemother,2010

4. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems;Daikos;Antimicrob Agents Chemother,2014

5. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients;Balandin Moreno;Scand J Infect Dis,2014

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing Klebsiella pneumoniae Clinical Isolates;Antibiotics;2024-06-04

2. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology;Chemical Reviews;2024-02-21

3. Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance;Antibiotics;2023-11-10

4. Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation;mSphere;2023-10-24

5. Karbapenemaz Üreten Klebsiella pneumoniae İzolatlarında Seftazidim-Avibaktam, Meropenem-Vaborbaktam ve İmipenem-Relebaktam İnvitro Etkinliğinin Gözden Geçirilmesi;Mediterranean Journal of Infection Microbes and Antimicrobials;2023-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3